190 related articles for article (PubMed ID: 19245532)
1. The incidence of idiopathic thrombocytopenic purpura among adults: a population-based study and literature review.
Abrahamson PE; Hall SA; Feudjo-Tepie M; Mitrani-Gold FS; Logie J
Eur J Haematol; 2009 Aug; 83(2):83-9. PubMed ID: 19245532
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database.
Schoonen WM; Kucera G; Coalson J; Li L; Rutstein M; Mowat F; Fryzek J; Kaye JA
Br J Haematol; 2009 Apr; 145(2):235-44. PubMed ID: 19245432
[TBL] [Abstract][Full Text] [Related]
3. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.
Terrell DR; Beebe LA; Vesely SK; Neas BR; Segal JB; George JN
Am J Hematol; 2010 Mar; 85(3):174-80. PubMed ID: 20131303
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom.
Bennett D; Hodgson ME; Shukla A; Logie JW
Adv Ther; 2011 Dec; 28(12):1096-104. PubMed ID: 22139790
[TBL] [Abstract][Full Text] [Related]
5. Renal impairment, hemoglobinuria, and hemoglobinemia among patients with idiopathic thrombocytopenic purpura.
Xue F; Wentworth C; Ganesh V; Gastanaga V; Stryker S; Cha S; Zhao S
Am J Hematol; 2011 Sep; 86(9):738-42. PubMed ID: 21786287
[TBL] [Abstract][Full Text] [Related]
6. Risk of cataract among idiopathic thrombocytopenic purpura patients in the UK general practice research database.
Feudjo-Tepie MA; Hall SA; Logie J; Robinson NJ
Pharmacoepidemiol Drug Saf; 2009 May; 18(5):380-5. PubMed ID: 19241439
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic thrombocytopenic purpura is strongly associated with higher prevalence of aortic valve disease.
Haseefa F; Movahed MR; Hashemzadeh M; Hashemzadeh M
Ann Hematol; 2020 Sep; 99(9):2081-2084. PubMed ID: 32691113
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database.
Yong M; Schoonen WM; Li L; Kanas G; Coalson J; Mowat F; Fryzek J; Kaye JA
Br J Haematol; 2010 Jun; 149(6):855-64. PubMed ID: 20377590
[TBL] [Abstract][Full Text] [Related]
9. Incidence of childhood primary immune thrombocytopenic purpura.
Higashigawa M; Maeyama T; Yoshino A; Matsuda K; Ito M; Maji T; Ichimi R
Pediatr Int; 2015 Oct; 57(5):1041-3. PubMed ID: 26508193
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.
Hazzan R; Mukamel M; Yacobovich J; Yaniv I; Tamary H
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):657-9. PubMed ID: 16933242
[TBL] [Abstract][Full Text] [Related]
11. Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura.
Szende A; Brazier J; Schaefer C; Deuson R; Isitt JJ; Vyas P
Curr Med Res Opin; 2010 Aug; 26(8):1893-903. PubMed ID: 20553121
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies.
Langeberg WJ; Schoonen WM; Eisen M; Gamelin L; Stryker S
Int J Hematol; 2016 Jun; 103(6):655-64. PubMed ID: 27084254
[TBL] [Abstract][Full Text] [Related]
13. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.
Glanz J; France E; Xu S; Hayes T; Hambidge S
Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170
[TBL] [Abstract][Full Text] [Related]
14. Immune thrombocytopenic purpura increased risk of subsequent pancreatitis: A Nationwide population cohort study.
Wu SC; Lin SF; Fang CW; Tsai IJ; Yang WC
Sci Rep; 2019 Nov; 9(1):16923. PubMed ID: 31729447
[TBL] [Abstract][Full Text] [Related]
15. Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.
An R; Wang PP
Vasc Health Risk Manag; 2017; 13():15-21. PubMed ID: 28176930
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of immune thrombocytopenic purpura.
Fogarty PF; Segal JB
Curr Opin Hematol; 2007 Sep; 14(5):515-9. PubMed ID: 17934361
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prevalence of immune thrombocytopenia under the copayment waiver policy for pediatric patients in Korea: Data from the National Health Claims Database.
Park SH; Kwak SG; Kim JY
Lupus; 2021 Apr; 30(4):655-660. PubMed ID: 33593162
[TBL] [Abstract][Full Text] [Related]
18. Immune thrombocytopenic purpura: epidemiology and implications for patients.
Michel M
Eur J Haematol Suppl; 2009 Mar; (71):3-7. PubMed ID: 19200301
[TBL] [Abstract][Full Text] [Related]
19. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
Watts RG
Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
